Authors:
BAGEL J
GARLAND WT
BRENEMAN D
HOLICK M
LITTLEJOHN TW
CROSBY D
FAUST H
FIVENSON D
NICHOLS J
Citation: J. Bagel et al., ADMINISTRATION OF DAB(389)IL-2 TO PATIENTS WITH RECALCITRANT PSORIASIS - A DOUBLE-BLIND, PHASE-II MULTICENTER TRIAL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 938-944
Citation: G. Saed et al., THE ROLE OF APOPTOSIS AND P53 IN THE PATHOGENESIS OF KELOIDS, Journal of investigative dermatology, 110(4), 1998, pp. 597-597
Authors:
CHOUCAIR M
LADIN D
OLSON J
HAN X
SAED G
FIVENSON D
Citation: M. Choucair et al., ANTI-BETA-1 INTEGRIN TREATMENT SELECTIVELY INDUCES APOPTOSIS IN KELOID FIBROBLASTS, Journal of investigative dermatology, 110(4), 1998, pp. 598-598
Authors:
FIVENSON D
MAX J
KALAAJI A
OLSON J
HAN X
SAED G
Citation: D. Fivenson et al., CYTOKINE MODULATION IN THE RESPONSE TO PUVA - A CTCL ORGAN-CULTURE MODEL, Journal of investigative dermatology, 110(4), 1998, pp. 654-654
Authors:
CHOUCAIR M
KALAAJI A
OLSON J
HAN X
FIVENSON D
Citation: M. Choucair et al., IMMUNOMODULATORY EFFECTS OF CHLOROQUINE ON KERATINOCYTE-DERIVED CYTOKINES IN RESPONSE TO ULTRAVIOLET-LIGHT (UVL), Journal of investigative dermatology, 110(4), 1998, pp. 694-694
Authors:
SAED GM
LADIN D
OLSON J
HAN XF
HOU ZZ
FIVENSON D
Citation: Gm. Saed et al., ANALYSIS OF P53 GENE-MUTATIONS IN KELOIDS USING POLYMERASE CHAIN REACTION-BASED SINGLE-STRAND CONFORMATIONAL POLYMORPHISM AND DNA-SEQUENCING, Archives of dermatology, 134(8), 1998, pp. 963-967
Citation: G. Saed et al., APOPTOSIS REGULATION IN THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMA(CTCL), Journal of investigative dermatology, 108(4), 1997, pp. 437-437
Authors:
LIEPA A
BENNETT CL
YARNOLD PR
ENAS N
LOZANO J
KUZEL T
OLSON E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSCROFF A
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
NICHOLS J
Citation: A. Liepa et al., CHANGES IN QUALITY-OF-LIFE (QOL) FOR PATIENTS (PTS) ENROLLED IN A PHASE-III TRIAL OF TREATMENT WITH A DIPHTHERIA-TOXIN FUSION PROTEIN (DAB(389)IL-2) FOR MYCOSIS-FUNGOIDES (MF), Blood, 90(10), 1997, pp. 3924-3924
Authors:
BACHA P
FOWLIE A
GRIMALDO D
HILLIER J
OLSEN E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSEROFF A
KUZEL T
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
Citation: P. Bacha et al., ANTIBODY AND PHARMACOKINETIC ANALYSIS FROM A PIVOTAL TRIAL OF ONTAK(TM) (DAB(389)IL-2) FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 90(10), 1997, pp. 1457-1457
Authors:
KUZEL T
OLSEN E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSEROFF A
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
NICHOLS J
BACHA P
Citation: T. Kuzel et al., PIVOTAL PHASE-III TRIAL OF 2 DOSE LEVELS OF DAB(389)IL-2 (ONTAK(TM)) FOR THE TREATMENT OF MYCOSIS-FUNGOIDES (MF), Blood, 90(10), 1997, pp. 2607-2607
Authors:
FIVENSON D
FARIA D
NICKOLOFF B
POVERINI P
KUNKEL S
BURDICK M
STRIETER R
Citation: D. Fivenson et al., CXC CHEMOKINE EFFLUX DURING CHRONIC WOUND-HEALING - CRITICAL ROLE OF THE ELR MOTIF IN ANGIOGENESIS, Journal of investigative dermatology, 104(4), 1995, pp. 625-625
Authors:
EMARA M
HOU ZZ
FARIA D
FIVENSON D
LADIN D
Citation: M. Emara et al., CHRONIC WOUND FLUID IS IMMUNOSUPPRESSIVE VIA AN INHIBITION OF T-CELL MITOGENESIS, Journal of investigative dermatology, 104(4), 1995, pp. 648-648
Authors:
FIVENSON D
ELKHEIMI M
CHRISTOPHERSON P
SAED G
NICKOLOFF B
Citation: D. Fivenson et al., MODULATION OF IL-10 EXPRESSION IN HUT78 CELLS - INSIGHTS INTO THE PATHOBIOLOGY AND TREATMENT OF CTCL, Journal of investigative dermatology, 104(4), 1995, pp. 648-648
Citation: Z. Hou et al., HYPOXIA DOES NOT ALTER CYTOKINE PRODUCTION BY KELOID FIBROBLASTS, Journal of investigative dermatology, 104(4), 1995, pp. 669-669
Authors:
GRINER J
FARIA D
LADIN D
SAED G
JURATLI M
FIVENSON D
Citation: J. Griner et al., MODULATION OF CHRONIC WOUND CYTOKINE PROFILE AFTER AUTOLOGOUS KERATINOCYTE GRAFTING, Journal of investigative dermatology, 102(4), 1994, pp. 579-579
Citation: D. Fivenson et al., MODULATION OF IL-10 EXPRESSION IN HUT78 CELLS - INSIGHTS INTO THE PATHOBIOLOGY AND TREATMENT OF CTCL, Clinical research, 42(2), 1994, pp. 10000232-10000232